Is Organogenesis Holdings Inc. (ORGO) Losing Momentum? BTIG Pulls Buy Rating After Q1 Update
TheFly reported on May 8 that BTIG downgraded ORGO to Neutral from Buy in a post–first-quarter update, with the price target withdrawn.
Organogenesis Holdings Inc. (ORGO)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Soleus Capital Guy Levy | 10,085,951 | $23,903,704 | +2% | 0.97% |
| 2. | D E Shaw D. E. Shaw | 2,297,974 | $5,446,198 | +16% | 0% |
| 3. | Renaissance Technologies Jim Simons | 1,068,538 | $2,532,435 | +31% | 0% |
| 4. | AQR Capital Management Cliff Asness | 881,717 | $2,089,669 | +38% | 0% |
| 5. | Sphera Global Healthcare Fund Doron Breen And Mori Arkin | 550,000 | $1,303,500 | 0.21% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.68 | 5,000 | $13,405.00 | 291,014 | 2026-03-09 | Filing | |
| $2.67 | 10,000 | $26,688.00 | 225,707 | 2026-03-09 | Filing | |
| $2.99 | 107,494 | $320,998.58 | 358,495 | 2025-05-15 | Filing | |
| $3.09 | 251,001 | $775,040.89 | 251,001 | 2025-05-14 | Filing | |
| $2.99 | 9,022 | $26,948.71 | 846,459 | 2025-06-06 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.14 | 200,000 | $1,027,060.00 | 2,565,591 | 2025-12-16 | Filing | |
| $5.29 | 187,957 | $994,292.53 | 2,765,591 | 2025-11-26 | Filing | |
| $5.30 | 12,043 | $63,827.90 | 2,953,548 | 2025-11-25 | Filing | |
| $5.34 | 100,000 | $534,000.00 | 2,965,591 | 2025-11-24 | Filing | |
| $3.56 | 18,620 | $66,255.55 | 335,719 | 2025-06-10 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 11,616,795 | $27,531,804 | 0% | |
| 2. | 4,899,751 | $11,612,411 | 0% | |
| 3. | 3,498,533 | $8,291,523 | 0.74% | |
| 4. | 2,900,816 | $6,874,934 | 0% | |
| 5. | 2,891,006 | $6,850,893 | 0% |
News See All
8 Best Small Cap Pharma Stocks to Buy Right Now
Despite the concerns surrounding the Iran War, Haig Bathgate, CEO of Callanish Capital, stated on CNBC on May 7 that he was optimistic about global stocks.
Organogenesis Holdings Inc. (NASDAQ:ORGO) Q1 2026 Earnings Call Transcript
Operator: Welcome, ladies and gentlemen, to the First Quarter 2026 Earnings Conference Call for Organogenesis Holdings, Inc.
Organogenesis Holdings Inc. (NASDAQ:ORGO) Q4 2025 Earnings Call Transcript
Operator: Welcome, ladies and gentlemen, to the Fourth Quarter and Full Year 2025 Earnings Conference Call for Organogenesis Holdings, Inc.
Organogenesis Holdings Inc. (NASDAQ:ORGO) Q3 2025 Earnings Call Transcript
Operator: Welcome, ladies and gentlemen, to the Third Quarter 2025 Earnings Conference Call of Organogenesis Holdings, Inc.
Organogenesis Holdings Inc. (NASDAQ:ORGO) Q2 2025 Earnings Call Transcript
Operator: Welcome, ladies and gentlemen, to the Second Quarter 2025 Earnings Conference Call for Organogenesis Holdings, Inc.
Organogenesis Holdings Inc. (NASDAQ:ORGO) Q1 2025 Earnings Call Transcript
Operator: Welcome, ladies and gentlemen, to the First Quarter 2025 Earnings Conference Call for Organogenesis Holdings Inc. At this time, all participants have been placed in a listen-only mode.
Organogenesis Holdings Inc. (NASDAQ:ORGO) Q4 2024 Earnings Call Transcript
Operator: Please standby. Welcome, ladies and gentlemen, to the Fourth Quarter and Fiscal Year 2024 Earnings Conference Call for Organogenesis Holdings, Inc.
Organogenesis Holdings Inc. (NASDAQ:ORGO) Q3 2024 Earnings Call Transcript
Operator: Please stand by. Welcome ladies and gentlemen to the Third Quarter of Fiscal Year 2024 Earnings Conference Call for Organogenesis Holdings Inc.
Organogenesis Holdings Inc. (NASDAQ:ORGO) Q2 2024 Earnings Call Transcript
Operator: Please stand by. Welcome ladies and gentlemen to the Second Quarter 2024 Earnings Conference Call for Organogenesis Holdings Inc.